Cited by 251Nerve injury and regenerationHereditary Neurological DisordersAutophagy in Disease and Therapy

A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration ( Wld S ) mouse

Open access
Conforti, Laura, Tarlton, Andrea, Mack, Till G. A., Mi, Weiqian, Buckmaster, E. Anne, Wagner, Diana, Perry, V. Hugh, Coleman, Michael P.·2000·Proceedings of the National Academy of Sciences

Abstract

Exons of three genes were identified within the 85-kilobase tandem triplication unit of the slow Wallerian degeneration mutant mouse, C57BL/ Wld S . Ubiquitin fusion degradation protein 2 ( Ufd2 ) and a previously undescribed gene, D4Cole1e , span the proximal and distal boundaries of the repeat unit, respectively. They have the same chromosomal orientation and form a chimeric gene when brought together at the boundaries between adjacent repeat units in Wld S . The chimeric mRNA is abundantly expressed in the nervous system and encodes an in-frame fusion protein consisting of the N-terminal 70 amino acids of Ufd2 , the C-terminal 302 amino acids of D4Cole1e , and an aspartic acid formed at the junction. Antisera raised against synthetic peptides detect the expected 43-kDa protein specifically in Wld S brain. This expression pattern, together with the previously established role of ubiquitination in axon degeneration, makes the chimeric gene a promising candidate for Wld . The third gene altered by the triplication, Rbp7 , is a novel member of the cellular retinoid-binding protein family and is highly expressed in white adipose tissue and mammary gland. The whole gene lies within the repeat unit leading to overexpression of the normal transcript in Wld S mice. However, it is undetectable on Northern blots of Wld S brain and seems unlikely to be the Wld gene. These data reveal both a candidate gene for Wld and the potential of the Wld S mutant for studies of ubiquitin and retinoid metabolism.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.97.21.11377

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The protective effects in WldS mice are attributed to a chimeric gene Ube4b/NMNAT1, which encodes an in-frame fusion protein of the amino-terminal of UBE4B and the complete coding region of NMNAT1.

    “The protective effects occurring in these mice are attributed to a chimeric gene Ube4b/NMNAT1, which encodes an in-frame fusion protein of the amino-terminal of ubiquitination factor E4B (UBE4B) and the complete coding region of NMNAT1 (83,84).”

    From CREB-activity and nmnat2 transcription are down-regulated prior to neurodegeneration, while NMNAT2 over-expression is neuroprotective, in a mouse model of human tauopathy (2012) · cites this paper as [83]

    The Results identify a WldS-specific in-frame fusion of the N-terminal 70 amino acids of Ufd2 and the C-terminal 302 amino acids of D4Cole1e. The Abstract and Discussion call it a promising candidate for slowing Wallerian degeneration, not an established cause of protection. Our copy does not identify D4Cole1e as NMNAT1 or say that the fusion contains NMNAT1’s complete coding region. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 29

  1. [1]Lunn E R, Perry V H, Brown M C, Rosen H, Gordon S. Eur J Neurosci. 1989;1:27–33. doi: 10.1111/j.1460-9568.1989.tb00771.x. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
  2. [2]Waller A. Philos Trans R Soc London. 1850;140:423–429. [Google Scholar]
  3. [3]Dal Canto M C, Gurney M E. Brain Res. 1995;676:25–40. doi: 10.1016/0006-8993(95)00063-v. [DOI] [PubMed] [Google Scholar] · DOI
  4. [4]Fujimura H, Lacroix C, Said G. Brain. 1991;114:1929–1942. doi: 10.1093/brain/114.4.1929. [DOI] [PubMed] [Google Scholar] · DOI
  5. [5]Buckmaster E A, Perry V H, Brown M C. Eur J Neurosci. 1995;7:1596–1602. doi: 10.1111/j.1460-9568.1995.tb01155.x. [DOI] [PubMed] [Google Scholar] · DOI
  6. [6]Finn J T, Weil M, Archer F, Siman R, Srinivasan A, Raff M C. J Neurosci. 2000;20:1333–1341. doi: 10.1523/JNEUROSCI.20-04-01333.2000. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  7. [7]Bernier B, Castejon S, Culver D G, Glass J D. NeuroReport. 1999;10:1423–1426. doi: 10.1097/00001756-199905140-00007. [DOI] [PubMed] [Google Scholar] · DOI
  8. [8]Lyon M F, Ogunkolade B W, Brown M C, Atherton D J, Perry V H. Proc Natl Acad Sci USA. 1993;90:9717–9720. doi: 10.1073/pnas.90.20.9717. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  9. [9]Coleman M P, Conforti L, Buckmaster E A, Tarlton A, Ewing R M, Brown M C, Lyon M F, Perry V H. Proc Natl Acad Sci USA. 1998;95:9985–9990. doi: 10.1073/pnas.95.17.9985. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  10. [10]Timmerman V, Nelis E, Van Hul W, Nieuwenhuijsen B W, Chen K L, Wang S, Ben Othmane K, Cullen B, Leach R J, Hanemann C O, et al. Nat Genet. 1992;1:171–175. doi: 10.1038/ng0692-171. [DOI] [PubMed] [Google Scholar] · DOI
  11. [11]de The H, Chomienne C, Lanotte M, Degos L, Dejean A. Nature (London) 1990;347:558–561. doi: 10.1038/347558a0. [DOI] [PubMed] [Google Scholar] · DOI
  12. [12]Kleinjan D J, van Heyningen V. Hum Mol Genet. 1998;7:1611–1618. doi: 10.1093/hmg/7.10.1611. [DOI] [PubMed] [Google Scholar] · DOI
  13. [13]Conforti L, Buckmaster E A, Tarlton A, Brown M C, Lyon M F, Perry V H, Coleman M P. Mamm Genome. 1999;10:617–622. doi: 10.1007/s003359901056. [DOI] [PubMed] [Google Scholar] · DOI
  14. [14]Sambrook J, Fritsch E F, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd Ed. Plainview, NY: Cold Spring Harbor Lab. Press; 1989. [Google Scholar]
  15. [15]Chomczynski P, Sacchi N. Anal Biochem. 1978;162:156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar] · DOI
  16. [16]Liu F-T, Zinnecker M, Hamaoka T, Katz D H. Biochemistry. 1979;18:690–697. doi: 10.1021/bi00571a022. [DOI] [PubMed] [Google Scholar] · DOI
  17. [17]Koegl M, Hoppe T, Schlenker S, Ulrich H D, Mayer T U, Jentsch S. Cell. 1999;96:635–644. doi: 10.1016/s0092-8674(00)80574-7. [DOI] [PubMed] [Google Scholar] · DOI
  18. [18]Smith W C, Nakshatri H, Leroy P, Rees J, Chambon P. EMBO J. 1991;10:2223–2230. doi: 10.1002/j.1460-2075.1991.tb07758.x. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  19. [19]Nakshatri H, Chambon P. J Biol Chem. 1994;269:890–902. [PubMed] [Google Scholar]
  20. [20]Mori H, Kondo J, Ihara Y. Science. 1987;235:1641–1644. doi: 10.1126/science.3029875. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
  21. [21]Li K, Ito H, Tanaka K, Hirano A. J Neuropathol Exp Neurol. 1997;56:125–131. doi: 10.1097/00005072-199702000-00002. [DOI] [PubMed] [Google Scholar] · DOI
  22. [22]DiFiglia M, Sapp E, Chase K O, Davies S W, Bates G P, Vonsattel J P, Aronin N. Science. 1997;277:1990–1993. doi: 10.1126/science.277.5334.1990. [DOI] [PubMed] [Google Scholar] · DOI
  23. [23]Cummings C J, Mancini M A, Antalffy B, DeFranco D B, Orr H T, Zoghbi H Y. Nat Genet. 1998;19:148–154. doi: 10.1038/502. [DOI] [PubMed] [Google Scholar] · DOI
  24. [24]Spittaels K, Van den Haute C, Van Dorpe J, Bruynseels K, Vandezande K, Laenen I, Geerts H, Mercken M, Sciot R, Van Lommel A, et al. Am J Pathol. 1999;155:2153–2165. doi: 10.1016/S0002-9440(10)65533-2. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  25. [25]Li G L, Farooque M. Acta Neuropathol. 1996;91:155–160. doi: 10.1007/s004010050407. [DOI] [PubMed] [Google Scholar] · DOI
  26. [26]Saigoh K, Wang Y L, Suh J G, Yamanishi T, Sakai Y, Kiyosawa H, Harada T, Ichihara N, Wakana S, Kikuchi T, et al. Nat Genet. 1999;23:47–51. doi: 10.1038/12647. [DOI] [PubMed] [Google Scholar] · DOI
  27. [27]Sidell N, Altman A, Haussler M R, Seeger R C. Exp Cell Res. 1983;148:21–30. doi: 10.1016/0014-4827(83)90184-2. [DOI] [PubMed] [Google Scholar] · DOI
  28. [28]Troen G, Eskild W, Fromm S H, De Luca L M, Ong D E, Wardlaw S A, Reppe S, Blomhoff R. J Nutr. 1999;129:1621–1627. doi: 10.1093/jn/129.9.1621. [DOI] [PubMed] [Google Scholar] · DOI
  29. [29]Ghyselinck N B, Bavik C, Sapin V, Mark M, Bonnier D, Hindelang C, Dierich A, Nilsson C B, Hakansson H, Sauvant P, et al. EMBO J. 1999;18:4903–4914. doi: 10.1093/emboj/18.18.4903. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI

Cited by

Sorted by citations

Authors
Conforti, L., Tarlton, A., Mack, T. G. A., Mi, W., Buckmaster, E. A., Wagner, D., Perry, V. H., & Coleman, M. P.
Affiliations
University of Oxford (GB)
Venue
Proceedings of the National Academy of Sciences
Published
2000-10-10
Volume
97
Issue
21
Pages
11377-11382
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2149931901
Cited by
251
References
0
Citations by year
2026: 3 · 2025: 2 · 2024: 3 · 2023: 2 · 2022: 7 · 2021: 9 · 2020: 3 · 2019: 7 · 2018: 3 · 2017: 4 · 2016: 9 · 2015: 8 · 2014: 8 · 2013: 13 · 2012: 14
FWCI
5.03
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • ePrints Soton (University of Southampton) (submittedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
Keywords
fusion genes, axonal degeneration, ubiquitination, vitamin A metabolism, candidate genes
MeSH terms
Amino Acid Sequence, Animals, Base Sequence, Central Nervous System, Exons, Fungal Proteins, Mice, Inbred C57BL, Molecular Sequence Data, Nicotinamide-Nucleotide Adenylyltransferase, Proteins, Recombinant Fusion Proteins, Retinol-Binding Proteins, RNA, Messenger, Wallerian Degeneration, Sequence Homology, Amino Acid, Peripheral Nervous System, DNA, Complementary, Saccharomyces cerevisiae Proteins, Ubiquitin-Conjugating Enzymes, Mice, Retinol-Binding Proteins, Cellular

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review